MOTS-c
A mitochondrial peptide with a real research story and a marketing phrase that runs past it.
- Explored for metabolic and insulin-sensitivity support
- Considered alongside a measured metabolic picture rather than on symptoms
Explored, not established. The research is largely preclinical, and nothing here replaces training, nutrition or sleep.
Pricing confirmed after eligibility · prescription treatment
What MOTS-c is
MOTS-c is a peptide encoded in mitochondrial rather than nuclear DNA, which is what makes it scientifically interesting. It has been studied for a role in insulin sensitivity and metabolic regulation, overwhelmingly in cell and animal work. It is prepared by a licensed compounding pharmacy under a prescription written for you and is not FDA-approved.
How it works here
Every plan follows one path. Each step feeds the next. See the Peptide Therapy approach.
- 01
Measure
We baseline your labs, history, and goals.
- 02
Plan
A clinician decides whether this fits — and what else might serve you.
- 03
Act
If appropriate, you start with clear guidance and high-touch support.
- 04
Track
We monitor how you respond on a defined cadence.
- 05
Adjust
Protocols are refined over time. Guided care, not a kit in the mail.
Delivery
A compounded preparation, dispensed by a licensed pharmacy on an individual prescription. How it is taken is set by the prescribing clinician after a review.
Is it right for you?
Adults over 45 whose metabolic markers have actually been measured and who want a considered addition to a plan rather than a shortcut. Start with lab testing — without a baseline there is nothing to judge a response against. See peptide therapy.
Often considered alongside
Epithalon
CompoundedThe longevity peptide with the boldest claims attached and the least independent evidence behind them.
View treatmentNAD+ Injection
CompoundedA coenzyme central to cellular energy, explored to support energy and recovery in midlife.
View treatmentContinuous Glucose Monitor
Two weeks of real glucose data, read by a clinician alongside your labs — and an honest answer about whether you need it at all.
View treatmentProducts marked Compounded are prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved and are not equivalent to or interchangeable with any branded product.
An honest word on the evidence
MOTS-c has the most interesting biology in this group and, like the rest of it, very little human evidence. The work sits mostly in cells and animals; the FDA's advisory committee considered it in July 2026 in the context of obesity and osteoporosis, and recommended it for the 503A Bulks List on a narrow margin against FDA staff's own recommendation. It is often described as an exercise mimetic, which is a phrase from the laboratory rather than a claim anyone has demonstrated in people, and it is not a reason to train less. These peptides sit in an unsettled regulatory position. In April 2026 the FDA removed twelve peptide substances from Category 2 of its interim 503A bulk substances list, this one among them — a step that followed the nominators withdrawing their nominations rather than any safety finding, and one that does not by itself authorize compounding. In July 2026 the Pharmacy Compounding Advisory Committee voted on whether seven of them should be added to the 503A Bulks List. That vote is a recommendation, not a decision: formal addition requires notice-and-comment rulemaking, which has not completed. Nothing here is FDA-approved for any use.
Frequently asked questions
That phrase comes from laboratory work and oversells what has been shown in people. MOTS-c and exercise explains the distinction, and why nothing here substitutes for training.
Insulin sensitivity and metabolic regulation, mostly in cell and animal models. See the metabolic evidence.
Yes. Without a baseline there is no way to tell whether anything changed, which is the only measure that matters here.
No. It is not approved for any use.
See if MOTS-c fits your plan
The right plan begins with knowing where you are. Start with a short eligibility check and a baseline — and we'll tell you, honestly, what fits.
We measure first. Then we act.
ACT 2 Health provides clinician-led care. Treatments described are available only to eligible patients following clinical evaluation and within applicable regulations. This page is educational and is not medical advice. Individual results vary.